Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

NCT02382510 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: TRN-157
OTHER: Placebo
DRUG: Tiotropium

Sponsor

Theron Pharmaceuticals, Inc.